Brief: Piramal Pharma Says Piramal Pharma Solutions Announces Sterile Fill/Finish Program With Theratechnologies For Th1902 Peptide-Drug Conjugate
Jan 25 (Reuters) - Theratechnologies Inc TH.TO :
* PIRAMAL PHARMA LIMITED - PIRAMAL PHARMA SOLUTIONS
ANNOUNCES
STERILE FILL/FINISH PROGRAM WITH THERATECHNOLOGIES INC. FOR
TH1902 PEPTIDE-DRUG CONJUGATE
Source text for Eikon: ID:nCNWCtljJa
Further company coverage: TH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process